| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/20/2010 | WO2010017541A3 Compositions and methods for treatment of neurodegenerative disease |
| 05/20/2010 | WO2010017094A3 CURCUMIN DERIVATIVES FOR AMYLOID-β PLAQUE IMAGING |
| 05/20/2010 | WO2010012004A3 Monoclonal antibodies specific for pathological amyoid aggregates common to amyloids formed from proteins of differing sequence |
| 05/20/2010 | WO2010011315A3 Proteins for use in diagnosing and treating infection and disease |
| 05/20/2010 | US20100125099 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene |
| 05/20/2010 | US20100125094 Pyrrolidinyl modulators of nicotinic acetylcholine receptors |
| 05/20/2010 | US20100125092 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
| 05/20/2010 | US20100125087 New compounds 575 |
| 05/20/2010 | US20100125085 Pyridoindole modulators of nmda receptor and acetylcholinesterase |
| 05/20/2010 | US20100125082 New compounds 578 |
| 05/20/2010 | US20100125081 New compounds 574 |
| 05/20/2010 | US20100125079 Biphenyl compounds useful as muscarinic receptor antagonists |
| 05/20/2010 | US20100125078 Quinazoline derivatives as nk3 receptor antagonists |
| 05/20/2010 | US20100125077 Polymorphs of Brimonidine Pamoate |
| 05/20/2010 | US20100125074 Thieno-[2,3-d]Pyrimidine and Thieno-Pyridazine Compounds and Methods of Use |
| 05/20/2010 | US20100125070 Bupropion Metabolites and Methods of Their Synthesis and Use |
| 05/20/2010 | US20100125066 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
| 05/20/2010 | US20100125063 Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
| 05/20/2010 | US20100125062 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 05/20/2010 | US20100125054 Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
| 05/20/2010 | US20100125053 Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction |
| 05/20/2010 | US20100124560 Multi portion intra-oral dosage form and use thereof |
| 05/20/2010 | US20100124535 Aerosol Dispersions of Particles with Active Pharmaceutical Ingredients |
| 05/20/2010 | CA2745451A1 Compositions and methods for the treatment of altered a-synuclein function |
| 05/20/2010 | CA2743938A1 Substituted isoindoles as bace inhibitors and their use |
| 05/20/2010 | CA2743717A1 Azaquinolinone derivatives and uses thereof |
| 05/20/2010 | CA2743709A1 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 05/20/2010 | CA2743620A1 Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases |
| 05/20/2010 | CA2743558A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 05/20/2010 | CA2743531A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/20/2010 | CA2743491A1 Inhibition of mammalian target of rapamycin |
| 05/20/2010 | CA2742993A1 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 05/20/2010 | CA2742833A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 05/20/2010 | CA2742771A1 Modification of amyloid-beta load in non-brain tissue |
| 05/20/2010 | CA2742679A1 Biphenylacetamide derivatives |
| 05/20/2010 | CA2742486A1 Gamma secretase modulators |
| 05/20/2010 | CA2742472A1 Gamma secretase modulators |
| 05/20/2010 | CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 05/20/2010 | CA2742114A1 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound |
| 05/20/2010 | CA2742105A1 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
| 05/20/2010 | CA2740262A1 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
| 05/20/2010 | CA2739732A1 Organic nutrient salts, methods of preparation and uses |
| 05/20/2010 | CA2737587A1 Quinazoline derivatives as nk3 receptor antagonists |
| 05/19/2010 | EP2186830A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| 05/19/2010 | EP2186803A2 Substituted thioacetamides |
| 05/19/2010 | EP2186525A2 G-CSF for use in the treatment of Parkinson's disease |
| 05/19/2010 | EP2186518A1 Composition and methods for treatment of disorders of protein aggregation |
| 05/19/2010 | EP2186517A1 Use and methods of use for an antagonist of the serotin3 receptor (5-ht3) and a selective modulator of chloride channels for the treatment of addiction to or dependence on medicines/drugs or nervous system disorders |
| 05/19/2010 | EP2186516A1 Novel benzazepine derivative |
| 05/19/2010 | EP2186515A1 Pharmaceutical composition comprising the combination of an anti-depressive agent and an ansiolytic agent for control and treatment of depressive disorders |
| 05/19/2010 | EP2186511A1 Method of treating sleep disorders using eplivanserin |
| 05/19/2010 | EP2186507A2 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 05/19/2010 | EP2186407A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 05/19/2010 | EP2185592A1 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| 05/19/2010 | EP2185561A2 1,2,3,4-tetrahydropyrroloý1,2-a¨pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrroloý1,2-a¨ý1,4¨-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 05/19/2010 | EP2185558A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 05/19/2010 | EP2185557A2 Perharidines as cdk inhibitors |
| 05/19/2010 | EP2185556A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 05/19/2010 | EP2185553A1 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 05/19/2010 | EP2185551A2 Prodrugs of 2-amino-6-( { [2-(4-chlorphenyl)-1,3-thiazol-4-yl] methyl}thio)-4-[4-(2-hy-droxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 05/19/2010 | EP2185535A1 Sulfamide derivative useful for the treatment of epilepsy |
| 05/19/2010 | EP2185530A1 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 05/19/2010 | EP2185529A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/19/2010 | EP2185523A2 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 05/19/2010 | EP2185521A2 Compounds and methods for modulating rho gtpases |
| 05/19/2010 | EP2185512A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 05/19/2010 | EP2185511A2 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 05/19/2010 | EP2185505A2 Acyl-urea derivatives and uses thereof |
| 05/19/2010 | EP2185503A1 Monoamide derivatives as orexin receptor antagonists |
| 05/19/2010 | EP2185501A1 Salts of tramadol and naproxen and their crystal forms in the treatment of pain |
| 05/19/2010 | EP2185181A2 Therapeutic uses of gastrin-1 and g-pen-grgdspca |
| 05/19/2010 | EP2185177A1 Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent |
| 05/19/2010 | EP2185171A2 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 05/19/2010 | EP2185169A2 Use of vitex agnus castus extracts for preparing a medicament |
| 05/19/2010 | EP2185160A2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders |
| 05/19/2010 | EP2185155A1 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands |
| 05/19/2010 | EP2185149A1 Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
| 05/19/2010 | EP2185147A1 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof |
| 05/19/2010 | EP2185146A1 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid |
| 05/19/2010 | EP2184990A2 3' substituted compounds having 5-ht6 receptor affinity |
| 05/19/2010 | EP2184986A2 Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
| 05/19/2010 | EP2184981A1 Pyridine carboxamide orexin receptor antagonists |
| 05/19/2010 | EP1720871B1 3,5-disubstituted 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors |
| 05/19/2010 | EP1558246B1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 05/19/2010 | EP1463487B1 Liposomal delivery of vitamin e based compounds |
| 05/19/2010 | EP1438063B1 Glutation precursors for the treatment of neuropsychiatric disorders |
| 05/19/2010 | EP1208233B1 Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease |
| 05/19/2010 | EP1176970B1 Xenotransplant for cns therapy |
| 05/19/2010 | EP0888374B1 HIGH AFFINITY NUCLEIC ACID LIGANDS OF THE COMPLEMENT SYSTEM PROTEIN C1q |
| 05/19/2010 | CN1939515B Abstinence Chinese-medicinal preparation and its making method |
| 05/19/2010 | CN1927363B Health food, its preparation method and application |
| 05/19/2010 | CN101711244A 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 05/19/2010 | CN101711240A Sleep-improving agent |
| 05/19/2010 | CN101711236A n-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles |
| 05/19/2010 | CN101711234A New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 05/19/2010 | CN101711160A Composition for treating ischemic limb disease comprising stem cells derived from adipose tissue |
| 05/19/2010 | CN101709292A Recombinant adenovirus, and preparation method and application thereof |
| 05/19/2010 | CN101709078A immune-modulating peptide |
| 05/19/2010 | CN101708315A Chinese medicinal preparation for treating headache and preparation method thereof |
| 05/19/2010 | CN101708311A Chinese medicinal preparation for treating senile dementia |